Iberogast: qué es, cómo funciona y cuándo tomarlo

Iberogast drops: what they are, how they work & when to take

“Iberogast is one of the medicines I am proudest to recommend, precisely because it has real evidence behind it and not just laboratory marketing.” — Jorge Peláez, pharmacist

DATO CLÍNICO

Iberogast is registered as a herbal medicinal product (HMP) with the AEMPS, not as a food supplement. This implies regulatory assessment of quality, safety and efficacy.

Want to skip the full analysis? The most recommended in 2026 is .
VER FICHA →

What are Iberogast drops and what are they for exactly

Iberogast drops are a registered herbal medicinal product, not a food supplement — and that distinction matters. They have gone through a medicines authorisation process (as a traditional herbal medicinal product under EU rules), which means their safety data and appropriate use have been assessed by regulators. It’s not the same as an over-the-counter “herbal extract” with no formal medicines oversight.

The approved use is symptomatic relief of functional gastrointestinal disorders: functional dyspepsia (upper abdominal discomfort without an organic cause), irritable bowel syndrome (IBS) and functional bowel complaints more generally. It is not indicated for erosive gastritis, active peptic ulcer disease, or organic pathology such as Crohn’s disease.

Iberogast does not treat organic digestive disease. If symptoms persist for more than 4 weeks or are severe, speak to your GP before continuing.

The difference between functional dyspepsia and IBS is clinically relevant: both can involve abdominal pain, bloating and altered bowel habit, but the predominant location differs — upper abdomen (epigastrium) in dyspepsia, lower abdomen in IBS. Iberogast works across both because it has a multi-target mechanism.

Ingredients: the 9 herbs and their mechanism of action

Iberogast contains a standardised ethanolic extract of nine herbs in a hydroalcoholic solution: Iberis amara (fresh plant), chamomile, milk thistle, lemon balm, peppermint, fumitory, angelica, liquorice and greater celandine. Standardisation helps ensure consistency between batches — something you simply don’t get with homemade infusions.

The mechanism is multi-factorial: Iberis amara supports gastric emptying; peppermint and chamomile relax intestinal smooth muscle; liquorice may help reduce mucosal inflammation; lemon balm and angelica provide a mild anxiolytic effect that can make a real difference in people whose symptoms worsen with stress — more common than many realise.

Iberogast drops at Farma2Go: choose the format that suits you

All three formats contain the same formula. The best choice depends on how you plan to use it.

The IBEROGAST 50 ml is the one I dispense most often. A 4-week course at 20 drops three times daily uses around 30–35 ml, so it covers the full cycle with some margin. Sensible price, right amount. My go-to.

The IBEROGAST 20 ml is for people trying it for the first time or taking it travelling — roughly 10–12 days’ use, and it stays within the 100 ml cabin baggage limit for flights.

The IBEROGAST 100 ml is for regular users or households where more than one person uses it. The cost per millilitre is lower than the 50 ml bottle.

Iberogast drops dose: when to take them and how long for

Dose according to the product information: adults and adolescents >12 years, 20 drops three times daily; children 6–12 years, 15 drops; children 3–6 years, 10 drops. It is not recommended in children under 3 years.

Do not give to children under 3 years. In children aged 3 to 12 years, check with your child’s doctor before starting.

Taking it before meals or with meals, diluted in water, tea or juice, isn’t arbitrary. The excipient includes ethanol: on an empty stomach it can irritate. Taking it with food can also support its prokinetic effect on gastric emptying.

The ethanol excipient may be harmful in liver disease, alcohol dependence, epilepsy or with medicines incompatible with alcohol. Check the patient leaflet or ask your pharmacist.

A typical course is 4 weeks. Improvement is often noticed from day three or four; in chronic disorders it can take up to 2 weeks. If there’s no improvement after 4 weeks, you should rule out an organic cause with your GP. The most common mistake I see is taking it only when pain flares — it works best when taken consistently rather than as a “rescue” product.

Who Iberogast drops are for (and who they aren’t)

Iberogast tends to work well in people with confirmed functional symptoms: post-meal bloating, early satiety, epigastric burning without ulceration, intestinal cramping or IBS-type alternating diarrhoea and constipation. It can be particularly helpful when stress or anxiety plays a part — the gut–brain axis amplifies functional symptoms, and the lemon balm–angelica combination targets that aspect.

Absolute contraindications: hypersensitivity to any component (including allergies to Asteraceae such as chamomile or Iberis), severe liver disease and biliary obstruction. Greater celandine contains alkaloids with potential hepatotoxicity at high doses. At therapeutic doses the risk appears low, but cases have been described in the literature — a reason to use it correctly rather than avoid it altogether.

The EMA and national regulators have issued safety communications about potential hepatotoxicity linked to greater celandine. At recommended doses and in 4-week cycles, risk is low. Do not use Iberogast longer than advised without medical supervision.

In pregnancy and breastfeeding: there’s no absolute contraindication, but the patient information recommends caution. Greater celandine has shown genotoxicity signals in vitro (without evidence of human teratogenicity). In practice, I’d apply the precautionary principle: avoid in the first trimester and speak to your doctor in the second and third trimesters. During breastfeeding, it’s best avoided due to lack of data.

Pregnancy and breastfeeding: avoid unless specifically advised by a doctor, especially in the first trimester.

Iberogast drops side effects and common mistakes

Tolerability is generally good — adverse event rates comparable to placebo in published trials. The most common issues are mild nausea and transient stomach discomfort at the start, which you can often avoid by taking it with food.

The adverse effect that deserves specific attention is greater celandine-related hepatotoxicity. The EMA reviewed this risk in 2014: low at therapeutic doses and within 4-week courses, but not zero. Reported cases were mainly linked to single-herb products at higher doses or prolonged use. If you develop dark urine, yellowing of skin or eyes, marked fatigue or persistent nausea, stop immediately and seek medical advice.

\ r\ n
\ r\ n

WARNING SIGN: Dark urine, yellow skin/eyes, marked fatigue or persistent nausea during treatment → stop Iberogast and speak to a doctor urgently. This may indicate liver involvement.

\ r\ n
\ r\ n\ r\ n
\ r\ n

Do not use in people with active liver disease or a history of herb-induced liver injury.

\ r\ n
\ r\ n\ r\ n

Another common mistake: combining Iberogast with omeprazole assuming “more is more”. There’s no known pharmacological interaction, but if your diagnosis is functional dyspepsia without an organic cause, it’s worth reviewing whether a PPI is genuinely needed — long-term use isn’t risk-free. Iberogast also doesn’t treat H. pylori gastritis or active peptic ulcer disease: if you have confirmed H. pylori infection, treatment is antibiotic eradication therapy. Iberogast can be used alongside as symptomatic support, never as a substitute.

\ r\ n\ r\ n
\ r\ n

If you have diagnosed active peptic ulcer disease or confirmed H. pylori infection, speak to your GP before using Iberogast. It does not replace antibiotic eradication therapy.

\ r\ n
\ r\ n\ r\ n

Iberogast drops compared with other options

\ r\ n\ r\ n

Domperidone and metoclopramide tend to work better and faster for nausea and vomiting — no debate there. But they carry neurological/cardiac risks (dystonia with metoclopramide; QT prolongation with domperidone at higher doses) that limit their suitability for some people. For someone with chronic functional dyspepsia without prominent nausea, Iberogast often offers a calmer risk–benefit profile.

\ r\ n\ r\ n

Peppermint oil capsules (such as Colpermin) have solid evidence for IBS where spasm is prominent. Ford et al. (BMJ, 2008) showed superiority over placebo with an NNT of 4. If your main issue is colonic spasm, peppermint oil can be as effective as Iberogast with fewer components and often at lower cost — I’m happy to say that plainly.

\ r\ n\ r\ n

The advantage of Iberogast is that it acts across both upper and lower GI tract at the same time. When someone has mixed symptoms — dyspepsia “up top” plus IBS “down below” — combining nine extracts with complementary mechanisms makes pharmacological sense in a way peppermint alone can’t cover. That’s the profile where I’d recommend it without hesitation.

Comparison table: Iberogast

PlantPart usedMain documented function
Iberis amaraFresh plantGastric prokinetic, regulation of motility
ChamomileFlowersAntispasmodic, anti-inflammatory on mucosa
Milk thistleFruitsHepatoprotective, antioxidant
Lemon balmLeavesMild anxiolytic, antispasmodic
MintLeavesAntispasmodic, carminative
FumitoryAerial partsCholeretic, regulator of biliary tone
AngelicaRootCarminative, antispasmodic
LiquoriceRootAnti-inflammatory on gastric mucosa
Greater celandineAerial partsAntispasmodic on biliary tract

If you are unsure what to choose, this table sets out the objective criteria you need to bear in mind.

Preguntas frecuentes

What exactly is Iberogast used for?

Iberogast is indicated for the symptomatic relief of functional gastrointestinal disorders: functional dyspepsia (discomfort in the upper abdomen, feeling of fullness, non-ulcer heartburn), irritable bowel syndrome (IBS) (abdominal pain, bloating, altered bowel habit) and functional intestinal discomfort in general. It is not indicated for gastritis due to H. pylori, active peptic ulcer or inflammatory bowel disease.

How many drops of Iberogast should I take and when?

The approved dose for adults and adolescents over 12 years is 20 drops, three times a day, preferably before or during main meals, diluted in water, tea or juice. For children from 6 to 12 years: 15 drops three times a day. For children from 3 to 6 years: 10 drops three times a day. It is not recommended in children under 3 years of age.

Does Iberogast have serious side effects?

At the recommended doses and in treatments of up to 4 weeks, Iberogast has a favourable tolerability profile. The most frequent adverse effects are mild gastric discomfort at the start, generally avoidable by taking the product with food. The most relevant adverse effect to monitor is hepatotoxicity, associated with the greater celandine component: if during treatment you notice dark urine, yellow discolouration of the skin or mucous membranes, or intense unexplained tiredness, you must stop it immediately and consult your doctor.

Can you take Iberogast during pregnancy and breastfeeding?

There is no evidence of teratogenicity in humans, but the Summary of Product Characteristics recommends caution because there are no controlled studies in pregnant women and greater celandine has in vitro genotoxicity data in some studies. The precautionary principle advises avoiding Iberogast during the first trimester and consulting your doctor before using it in the second and third trimesters. During breastfeeding it is also recommended to avoid it due to lack of safety data.

How long does Iberogast take to work?

Most patients notice an improvement in symptoms from the third or fourth day of regular treatment. In chronic functional disorders it can take up to two weeks to really be felt. Taking it regularly, three times a day with meals, and not only when symptoms appear, is what

Referencias científicas

  • 14755152 [acceder] — PMID: 14755152
  • 12122614 [acceder] — PMID: 12122614
  • 19008265 [acceder] — PMID: 19008265
  • Allescher HD, Abdel-Aziz H (2020). Mechanism of Action of STW 5 in Functional Dyspepsia and IBS: The Origin of Multi-Target Mediators. Phytomedicine. [acceder] — PMID: 32008936
  • Madisch A, Holtmann G, Mayr G, Vinson B, Hotz J (2004). Treatment of functional dyspepsia with a herbal preparation: a double-blind, randomized, placebo-controlled, multicenter trial. Digestion. [acceder] — PMID: 14767182
Back to blog